The investigational drug BMS-986365 may help patients with mCRPC previously treated with ARPIs overcome drug resistance, despite their genomic status. The investigational dual androgen receptor ...
In recent study, incidence of CTRCD and LVEF 40% were higher in association with high- versus low-risk AI ECG screen. (HealthDay News) — For patients undergoing treatment for certain types of ...
Dual anti-PD1/CTLA-4 therapy with nivolumab plus ipilimumab appears more effective than monotherapy for select patients with mCRPC, but the combination is associated with high toxicity. Dual PD1 ...
Patients with pneumonia with elevated glucose upon admission had higher rates of ICU admission and slightly higher hospital lengths of stay. In patients hospitalized with pneumonia, elevated blood ...
Researchers sought to better understand the distinct immunological pathways in AAV and nephrotic syndrome, which could lead to better diagnosis. A better understanding of the distinct ...
No associations seen for preeclampsia or eclampsia or gestational diabetes. (HealthDay News) — A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD ...
Statin use demonstrated a protective effect against the occurrence and progression of NAFLD, especially among individuals with lower ASCVD risk. Statin use is associated with a reduced risk for ...
Chronic systemic low-grade inflammation may increase the risk for psychiatric disorders. Elevated inflammatory biomarkers – especially leukocytes and haptoglobin – are associated with an ...
Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...
Break Wave lithotripsy and ultrasonic propulsion are among the investigational noninvasive ultrasound procedures to treat kidney stones.
70.8% of those who were aware of their hypertension status and met criteria for meds had uncontrolled hypertension ...
Weight reduction at 1 year linked to medication active agent, dosage, treatment indication, persistence of coverage ...